Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial

By Kattan Michael W.  

Applied Health Economics and Health Policy, Vol. 9, Iss. 5, 2011-09 ,pp. : 305-315

Adis International

Access to resources Recommend Favorite

Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial

By Miles Fayth L.   Goodman Phyllis J.   Tangen Catherine   Torkko Kathleen C.   Schenk Jeannette M.   Song Xiaoling   Pollak Michael   Thompson Ian M.   Neuhouser Marian L.  

Nutrients, Vol. 9, Iss. 4, 2017-04 ,pp. : 378-378

MDPI

Access to resources Recommend Favorite

Knowledge of heart attack symptoms in 20 US communities. Results from the rapid early action for coronary treatment community trial

By Goff D.C.   Mitchell P.   Finnegan J.   Pandey D.   Bittner V.   Feldman H.   Meischke H.   Goldberg R.J.   Luepker R.V.   Raczynski J.M.   Cooper L.   Mann C.   for the REACT Study Group  

Preventive Medicine, Vol. 38, Iss. 1, 2004-01 ,pp. : 85-93

Elsevier

Access to resources Recommend Favorite

Fat, rich and beautiful: changing socio-cultural paradigms associated with obesity risk, nutritional status and refugee children from sub-Saharan Africa

By Renzaho A.M.N.  

Health and Place, Vol. 10, Iss. 1, 2004-03 ,pp. : 105-113

Elsevier

Access to resources Recommend Favorite

Where's the Fat? Trends in U.S. Diets 1965–1996

By Popkin B.M.   Siega-Riz A.M.   Haines P.S.   Jahns L.  

Preventive Medicine, Vol. 32, Iss. 3, 2001-03 ,pp. : 245-254

Academic Press

Access to resources Recommend Favorite